Biological Research For Nursing,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 16, 2024
Purpose:
Chronic
venous
leg
ulcers
(CVLUs)
comprise
the
majority
of
lower-extremity
wounds,
yet
their
pathophysiology
is
not
fully
understood.
While
research
has
shown
that
microRNAs
are
an
important
component
wound
inflammation,
few
have
explored
role
(miRNAs)
in
healing
CVLUs.
This
scoping
review
examines
miRNAs
CVLUs
and
association
with
healing.
Methods:
In
December
2023,
we
searched
MEDLINE/PubMed,
Embase,
Scopus,
CINAHL
for
studies
published
2013–2023
examining
CVLU
Results:
Six
met
inclusion
criteria.
MicroRNAs
were
extracted
from
various
specimens
including
serum,
skin
biopsy
samples,
adipose
tissue-derived
mesenchymal
cells
individuals
Overexpression
miR-221,
miR-222,
miR-92a,
miR-301a-3p
hindered
angiogenesis,
while
overexpression
miR-296,
miR-126,
miR-378,
miR-210
facilitated
angiogenesis.
miR-34a/c,
miR-301a-3p,
miR-450-5p,
miR-424-5p,
miR-516-5p,
miR-7704
increased
local
inflammatory
responses
inhibited
keratinocytes
proliferation,
impairing
healing,
miR-19a/b
miR-20
downregulated
keratinocytes'
response,
promoting
Downregulation
miR-205,
miR-96-5p,
miR-218-5p
enhanced
cellular
proliferation
promoted
miR-17–92
was
linked
impaired
Discussion:
play
a
regulating
responses,
cell
migration
chronic-wound
However,
limited
lack
standardized
approach
to
measurement
quantification.
Further
warranted
elucidate
mechanisms
underlying
microRNA
involvement
better
understand
future
development
targeted
therapies.
Biomaterials Research,
Год журнала:
2025,
Номер
29
Опубликована: Янв. 1, 2025
The
field
of
infected
wound
management
continues
to
face
challenges,
and
traditional
methods
used
cope
with
wounds
include
debridement,
gauze
coverage,
medication,
others.
Currently,
synthetic
natural
biomaterials
are
readily
available
today,
enabling
the
creation
new
dressings
that
substantially
enhance
healing.
Considerable
attention
is
being
paid
hydrogels
based
on
materials,
which
have
good
biocompatibility
degradability
properties,
while
exhibiting
higher
similarity
extracellular
matrix
as
compared
materials.
In
this
study,
we
extracted
active
ingredients
oxidized
konjac
glucomannan
(OKGM)
fresh
egg
white
(EW)
from
2
foods,
konjac,
egg,
respectively,
formed
a
self-repairing
hydrogel
cross-linking
Schiff
base.
Subsequently,
peptide,
glycyl-l-histidyl-l-lysine-Cu
(GHK-Cu),
was
loaded,
an
all-natural
composite
dressing,
EW/OKGM@GHK-Cu
(GEK),
developed.
GEK
hydrogel,
both
antibacterial
anti-inflammatory
plays
hemostatic
role
by
adhering
tissues
promoting
neovascularization
serves
optimal
dressing
for
skin
regeneration.
Taken
together,
derived
food
sources
therefore
constitute
efficient
cost-effective
strategy
managing
healing
significant
potential
clinical
application
transformation.
Theranostics,
Год журнала:
2024,
Номер
14(11), С. 4198 - 4217
Опубликована: Янв. 1, 2024
The
utilization
of
extracellular
vesicles
(EVs)
in
wound
healing
has
been
well-documented.However,
the
direct
administration
free
EVs
via
subcutaneous
injection
at
sites
may
result
rapid
dissipation
bioactive
components
and
diminished
therapeutic
efficacy.Functionalized
hydrogels
provide
effective
protection,
as
well
ensure
sustained
release
bioactivity
during
process,
making
them
an
ideal
candidate
material
for
delivering
EVs.In
this
review,
we
introduce
mechanisms
by
which
accelerate
healing,
then
elaborate
on
construction
strategies
engineered
EVs.Subsequently,
discuss
synthesis
application
delivery
systems
to
enhance
complicated
healing.Furthermore,
face
wounds,
functionalized
with
specific
microenvironment
regulation
capabilities,
such
antimicrobial,
anti-inflammatory,
immune
regulation,
used
loading
EVs,
potential
approaches
addressing
these
challenges.Ultimately,
deliberate
future
trajectories
outlooks,
offering
a
fresh
viewpoint
advancement
artificial
intelligence
(AI)-energized
materials
3D
bio-printed
multifunctional
hydrogel-based
dressings
biomedical
applications.
International Immunopharmacology,
Год журнала:
2024,
Номер
139, С. 112667 - 112667
Опубликована: Июль 16, 2024
Human
umbilical
cord
mesenchymal
stem
cells-derived
small
extracellular
vesicles
(MSC-sEV)
provide
a
pragmatic
solution
as
cell-free
therapy
for
patients
with
diabetic
kidney
disease
(DKD).
However,
the
underlying
protective
mechanisms
of
MSC-sEV
remain
largely
unknown
in
DKD.
Invivo
and
vitro
analyses
demonstrated
that
attenuated
renal
fibrosis
inflammation
The
mechanism
MSC-sEV-induced
therapeutic
effect
was
explored
by
high-throughput
sequencing,
which
identified
unique
enrichment
set
miRNAs
compared
human
skin
fibroblasts-sEV
(HSF-sEV).
Vitro
experiments
potential
primarily
attributed
to
miR-23a-3p,
one
most
abundant
MSC-sEV.
Further,
overexpression
or
knockdown
revealed
its
target
Krüppel-like
factor
3
(KLF3)
suppressed
STAT3
signaling
pathway
high
glucose
(HG)
induced
HK-2
cells
were
essential
renal-protective
property
Moreover,
we
found
miR-23a-3p
packaged
into
RNA
Binding
Motif
Protein
X-Linked
(RBMX)
transmitted
HG-induced
cells.
Finally,
inhibiting
could
mitigate
effects
db/db
mice.
These
findings
suggest
systemic
administration
sEV
derived
from
MSC,
have
capacity
incorporate
where
they
can
exert
against
injury
through
delivery
miR-23a-3p.
Polymers,
Год журнала:
2025,
Номер
17(7), С. 915 - 915
Опубликована: Март 28, 2025
The
use
of
miRNA
in
therapeutics
has,
since
its
discovery
1993,
attracted
tremendous
attention,
and
research
this
area
has
progressed
rapidly.
Since
the
advent
RNA
interference
(RNAi),
much
about
nucleic
acid
siRNA
been
elucidated.
At
same
time,
no
miRNA-based
drugs
have
passed
phase
II
clinical
trials.
A
significant
obstacle
to
drug
development
is
ease
degradation
relatively
short
half-life
vivo
miRNA.
Hydrogels
are
networks
cross-linked
polymer
chains
with
ability
'swell'.
They
shown
remarkable
capabilities
that
improve
properties
other
researched
carriers.
In
combination
modification
strategies
inorganic
carriers,
hydrogel
systems
show
promise
for
sustained
delivery
novel
drugs.
Although
reported
recently,
focus
predominantly
on
their
wound-healing
properties,
a
dearth
information
carrier
abilities.
This
paper
focuses
more
latest
advancements
developing
hydrogels
as
system,
emphasizing
review
will
cover
methods
fabrication,
efforts
release,
biomedical
applications,
future
prospects.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2025,
Номер
13
Опубликована: Март 3, 2025
Exosomes
are
double-membrane
vesicular
nanoparticles
in
the
category
of
extracellular
vesicles,
ranging
size
from
30
to
150
nm,
and
released
cells
through
a
specific
multi-step
exocytosis
process.
have
emerged
as
promising
tools
for
tissue
repair
due
their
ability
transfer
bioactive
molecules
that
promote
cell
proliferation,
differentiation,
regeneration.
However,
therapeutic
application
exosomes
is
hindered
by
rapid
clearance
body
limited
retention
at
injury
site.
To
overcome
these
challenges,
hydrogels,
known
high
biocompatibility
porous
structure,
been
explored
carriers
exosomes.
Hydrogels
can
provide
controlled
release
mechanism,
prolonging
time
targeted
tissues,
thus
enhancing
efficacy.
This
review
focuses
on
combination
different
with
hydrogels
context
repair.
We
first
introduce
sources
functions
exosomes,
particularly
those
mesenchymal
stem
cells,
roles
regenerative
medicine.
then
examine
various
types
highlighting
load
Several
strategies
encapsulating
discussed,
including
impact
hydrogel
composition
structure
exosome
delivery
efficiency.
Finally,
we
applications
exosomes-loaded
such
skin,
bone,
cartilage,
nerve,
explore
challenges
future
directions
this
field.
The
offers
significant
promise
advancing
therapies.
Signal Transduction and Targeted Therapy,
Год журнала:
2025,
Номер
10(1)
Опубликована: Март 10, 2025
Abstract
The
ability
of
small
nucleic
acids
to
modulate
gene
expression
via
a
range
processes
has
been
widely
explored.
Compared
with
conventional
treatments,
acid
therapeutics
have
the
potential
achieve
long-lasting
or
even
curative
effects
editing.
As
result
recent
technological
advances,
efficient
delivery
for
therapeutic
and
biomedical
applications
achieved,
accelerating
their
clinical
translation.
Here,
we
review
increasing
number
classes
most
common
chemical
modifications
platforms.
We
also
discuss
key
advances
in
design,
development
application
each
platform.
Furthermore,
this
presents
comprehensive
profiles
currently
approved
drugs,
including
11
antisense
oligonucleotides
(ASOs),
2
aptamers
6
siRNA
summarizing
modifications,
disease-specific
mechanisms
action
strategies.
Other
candidates
whose
trial
status
recorded
updated
are
discussed.
consider
strategic
issues
such
as
important
safety
considerations,
novel
vectors
hurdles
translating
academic
breakthroughs
clinic.
Small
produced
favorable
results
trials
address
previously
“undruggable”
targets,
suggesting
that
they
could
be
useful
guiding
additional
candidates.